Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8145)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2017 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Semb S, Helgstrand F, Hjørne F, Bytzer P. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World J Gastroenterol 2017; 23(37): 6907-6910 [PMID: 29085234 DOI: 10.3748/wjg.v23.i37.6907] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6907.htm |
| Number | Citing Articles |
| 1 |
R. Kettritz, F. C. Luft. Seltene Elektrolytstörungen. Der Nephrologe 2019; 14(2): 94 doi: 10.1007/s11560-018-0278-7
|
| 2 |
嘉豪 李. Common Adverse Reactions and Corresponding Management Measures of Cisplatin Combined with Gemcitabine in Chemotherapy. Advances in Clinical Medicine 2023; 13(12): 19087 doi: 10.12677/ACM.2023.13122684
|
| 3 |
Zuber Khan, Sidharth Mehan, Mohd. Anas Saifi, Ghanshyam Das Gupta, Acharan S. Narula, Reni Kalfin. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the
Dementia Connection and Co-morbid Risks. Current Alzheimer Research 2023; 20(11): 739 doi: 10.2174/0115672050289946240223050737
|
| 4 |
Rohit Tayal, Sabina Yasmin, Samrat Chauhan, Thakur Gurjeet Singh, Monika Saini, Eman Shorog, Maryam M. Althubyani, Baiaan H. Alsaadi, Fatimah Aljohani, Maram A. Alenazi, Sarah A. Abutaily, Mohammad Yousuf Ansari. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?. Pharmaceuticals 2023; 16(10): 1387 doi: 10.3390/ph16101387
|
| 5 |
|
| 6 |
Ho Seok Seo, Miyoung Choi, Sang-Yong Son, Min Gyu Kim, Dong-Seok Han, Han Hong Lee. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018. Journal of Gastric Cancer 2018; 18(4): 313 doi: 10.5230/jgc.2018.18.e41
|
| 7 |
Pim M. W. Janssens, Michiel W. Pot, Moniek Wouters, Henk J. van Leeuwen, Marcel M. G. J. van Borren. What extreme laboratory values can be obtained that (some) patients can survive with?. Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(1): 50 doi: 10.1080/00365513.2021.2015800
|
| 8 |
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations. Therapies 2021; 76(1): 13 doi: 10.1016/j.therap.2020.06.019
|
| 9 |
Jinfeng Zhang, Mingxi Lin, Yizi Jin, Linhan Gu, Ting Li, Baoying Yuan, Biyun Wang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Jian Zhang, Xichun Hu. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia. Breast Cancer Research and Treatment 2020; 182(3): 719 doi: 10.1007/s10549-020-05730-2
|
| 10 |
Paola Cabras, Michele Anedda, Laura Caddeo, Marongiu Francesco, Mameli Antonella. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy. American Journal of Therapeutics 2020; 27(6): e676 doi: 10.1097/MJT.0000000000001041
|